Adverse Effects of Ivermectin Used in Egypt During COVID-19

• Conditions: Covid19; Drug Toxicity; Drug Side Effect; Ivermectin Poisoning

• Registration Number: NCT04747678
• Lead Sponsor: Menoufia University

Brief Summary

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Detailed Description

ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose regimens

Study Timeline

• Status Verified: 2021-02
• Study First Submitted: 2021-02-01
• Study Start: 2021-02-03
• Study First Submitted QC: 2021-02-09
• Last Update Submitted: 2021-02-09
• Study First Posted: 2021-02-10
• Last Update Posted: 2021-02-10
• Primary Completion: 2021-02-28
• Study Completion: 2021-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• all people used ivermectin as a treatment or as a prophylactic in covid 19 pandemic in egypt with explained dose

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
all adverse effects will be collected from people used Ivermectin in between September 2020 to December 2020	the data will be collected from February 2021 to march 2021	all data will be collected from retrospective manner as a retrospective study

Secondary Outcome Measures

Name	Time	Method
all data will be arranged according to time and dose manner	February to match 2021	data for each dose will be identified together

Trial Locations

Locations (1)

Ahmed Mansour; 🇪🇬 Shibīn Al Kawm, Menoufia, Egypt